COVID-19 vaccination coverage by company size and the effects of workplace vaccination program in Japan: a cohort study.

Authors:
Mori K; Mori T; Nagata T; Ando H; Hino A and 4 more

Journal:
Environ Health Prev Med

Publication Year: 2022

DOI:
10.1265/ehpm.22-00091

PMCID:
PMC9283908

PMID:
35786684

Journal Information

Full Title: Environ Health Prev Med

Abbreviation: Environ Health Prev Med

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Environmental Health

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
4/6
66.7% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Declarations Ethical approval and consent to participateThis study was approved by the ethics committee of the University of Occupational and Environmental Health, Japan (reference nos. R2-079 and R3-006). Informed consent was obtained from all participants via the survey website. Consent for publicationNot applicable. Availability of data and materialData available on request from authors. Competing interestsThe authors declare that they have no competing interests. FundingThe study was supported and partly funded by research grants from the University of Occupational and Environmental Health, Japan (no grant number), the Japanese Ministry of Health, Labour and Welfare (H30-josei-ippan-002, H30-roudou-ippan-007, 19JA1004, 20JA1006, 210301-1, and 20HB1004), Anshin Zaidan (no grant number), the Collabo-Health Study Group (no grant number), Hitachi Systems, Ltd. (no grant number), and scholarship donations from Chugai Pharmaceutical Co., Ltd. (no grant number). The funders were not involved in the study design, collection, analysis, or interpretation of data, the writing of this article, or the decision to submit it for publication. Authors’ contributionsKM designed the analysis, analyzed the data, and wrote the manuscript. TM designed the analysis and reviewed the manuscript. TN created the questionnaire, advised on the study design and data interpretation, and reviewed the manuscript. HA, AH, ST, MT, and SM reviewed the manuscript and advised on the data interpretation. YF was chairperson of the study group, created the questionnaire, advised on the data interpretation, and reviewed the manuscript. AcknowledgmentsThe current members of the CORoNa Work Study, in alphabetical order, are as follows: Dr. Hajime Ando, Dr. Hisashi Eguchi, Dr. Yoshihisa Fujino (present chairperson of the study group), Dr. Arisa Harada, Dr. Ayako Hino, Dr. Kazunori Ikegami, Dr. Tomohiro Ishimaru, Dr. Kyoko Kitagawa, Ms. Ning Liu, Dr. Kosuke Mafune, Dr. Shinya Matsuda, Dr. Ryutaro Matsugaki, Dr. Koji Mori, Dr. Keiji Muramatsu, Dr. Masako Nagata, Dr. Tomohisa Nagata, Dr. Akira Ogami, Dr. Makoto Okawara, Dr. Rie Tanaka, Dr. Seiichiro Tateishi, Dr. Shinya Matsuda, Dr. Tomohiro Ishimaru, and Dr. Tomohisa Nagata. All members are affiliated with the University of Occupational and Environmental Health, Japan. We also thank Katherine Thieltges from Edanz (https://jp.edanz.com/ac) for editing a draft of this manuscript. Competing interests The authors declare that they have no competing interests."

Evidence found in paper:

"Funding The study was supported and partly funded by research grants from the University of Occupational and Environmental Health, Japan (no grant number), the Japanese Ministry of Health, Labour and Welfare (H30-josei-ippan-002, H30-roudou-ippan-007, 19JA1004, 20JA1006, 210301-1, and 20HB1004), Anshin Zaidan (no grant number), the Collabo-Health Study Group (no grant number), Hitachi Systems, Ltd. (no grant number), and scholarship donations from Chugai Pharmaceutical Co., Ltd. (no grant number). The funders were not involved in the study design, collection, analysis, or interpretation of data, the writing of this article, or the decision to submit it for publication."

Evidence found in paper:

"Trial registration Not applicable."

Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025